News

Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and ...
The American Society of Plastic Surgeons' (ASPS) annual trend-spotting report has arrived, plotting the popularity of plastic surgery and noninvasive procedures. Every year, it analyzes key shifts in ...
Appetite-suppressing drugs could wipe out millions of fast-food trips. What it means for your choices and your money.
The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...
Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
Terns' late-stage assets target CML & obesity with key data in Q4 2025. Explore their potential in massive markets. Click ...
Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...
Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...
WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...
Ozempic a drug touted as a magical driving force for weight loss may be negatively affecting intimacy between couples ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.